Oscar Health (NYSE:OSCR) Reaches New 12-Month High – Should You Buy?

Oscar Health, Inc. (NYSE:OSCR) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $25.58 and last traded at $25.3740, with a volume of 13753974 shares traded. The stock had previously closed at $23.32.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Zacks Research raised Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 7th. UBS Group lifted their price objective on Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Raymond James Financial upgraded Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective for the company in a report on Thursday, February 12th. Wolfe Research started coverage on Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating for the company. Finally, Wall Street Zen upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Saturday, May 9th. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Oscar Health has a consensus rating of “Hold” and an average price target of $18.22.

Oscar Health Trading Down 4.6%

The stock has a 50 day simple moving average of $16.13 and a 200-day simple moving average of $15.52. The firm has a market capitalization of $7.05 billion, a P/E ratio of -39.66, a P/E/G ratio of 1.71 and a beta of 2.34. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business’s quarterly revenue was up 52.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.92 EPS. On average, equities research analysts forecast that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Insider Transactions at Oscar Health

In other news, CFO Richard Scott Blackley sold 100,000 shares of Oscar Health stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the transaction, the chief financial officer directly owned 1,216,660 shares of the company’s stock, valued at $28,177,845.60. The trade was a 7.59% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Mark T. Bertolini acquired 1,000,000 shares of the stock in a transaction dated Monday, April 6th. The shares were bought at an average cost of $11.92 per share, for a total transaction of $11,920,000.00. Following the completion of the transaction, the chief executive officer owned 10,196,876 shares in the company, valued at approximately $121,546,761.92. This represents a 10.87% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 24.39% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Jones Financial Companies Lllp lifted its position in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares in the last quarter. Strs Ohio purchased a new position in shares of Oscar Health during the 1st quarter valued at about $30,000. Fifth Third Bancorp lifted its position in shares of Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after buying an additional 1,413 shares in the last quarter. Quarry LP lifted its position in shares of Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares in the last quarter. Finally, Tsfg LLC purchased a new position in shares of Oscar Health during the 3rd quarter valued at about $38,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.